Skip to Content
🌐Ship toSelect country

Pluryal Volume Lidocaine - 1 x 1,0ml

Pluryal Volume Lidocaine is the lidocaine-containing version of Pluryal Volume, a 23mg/ml cross-linked hyaluronic acid dermal filler designed to restore facial structures via deep/mid-dermal injection — boosting cheeks and lips, reshaping the nose, correcting mandibular contour and remodelling the chin or dorsum of the hands. The added lidocaine improves injection comfort; results reported to last 12-16 months. For use by licensed, trained medical professionals only.

68.95 € 68.95 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Pluryal, Pluryal
SKU A3515 Share
Treatment Areas CheeksChinFaceHandsJawlineLipsNose
Tags Cross-Linked Hyaluronic AcidHyaluronic AcidLidocaineVolumizer

Pluryal Volume Lidocaine is a cross-linked hyaluronic acid dermal filler from MD Skin Solutions (Luxembourg), formulated at 23mg/ml for deep dermis/subcutaneous injection. It is designed to restore lost volume in areas such as the cheeks, temples and chin, and to fill very deep wrinkles, with lidocaine added for a more comfortable injection experience.

CONCENTRATION

  • Cross-linked hyaluronic acid 23mg/ml
  • Lidocaine hydrochloride

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 12-16 months, per manufacturer data.

INDICATIONS

  • Loss of cheek, temple and chin volume
  • Very deep wrinkles and facial contour restoration

TREATMENT AREAS

  • Cheeks
  • Temples
  • Chin
  • Face, general

Pluryal Volume Lidocaine is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin